Cite Filings / XFOR / 9999999995-26-001669

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

X4 Pharmaceuticals, Inc Filed 2026-05-14 Acc 9999999995-26-001669

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-14 EFFECT Notice of Effectiveness
2026-05-13 8-K/A Executive or director change · Shareholder vote results
2026-05-13 4 Chief Financial Officer sold 16,961 shares at $4.29 ($72,820)
2026-05-12 8-K Executive or director change · Shareholder vote results
2026-05-12 144 Sale of Securities
2025-09-17 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…